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WHAT YOU’LL NEVER MANAGE TO READ – 
THE SMALL PRINT COMPONENT OF TELEVISED 
COMMERCIALS FOR ERECTION STIMULANTS 
The law is not effective in forcing the advertisers to communicate complete and 
reliable information about advertised products: the mere inclusion of written dis-
closures does not guarantee their successful perception, let alone comprehension. 
TV commercials are especially troublesome in this respect, because not only are the 
disclaimers presented in microscopic font size, but their display time challenges the 
perceptive abilities of even the most effi cient readers, not to mention the distract-
ing effect of the simultaneously presented visual images and voice-overs. Yet, their 
effective comprehension could very often signifi cantly modify the overall message 
and in this way lead to altered (often in a way unfavourable for the advertiser) 
persuasive effect. The study presents the ways in which the small print components 
interact with the information presented by means of the more conspicuous linguistic 
and pictorial items in a collection of 20 Polish TV commercials for erection stimu-
lants. In particular, attention is given to the potential changes in the communicated 
message in the conditions of full comprehension and intake of the small print items. 
1. Advertising communication and the law
Advertising, as a part of commercial activity, is subject to specifi c legal 
regulations pertaining to its subject matter, content, forms and practices. Free 
market does not entail total freedom of advertisers to choose what, how, when 
and to whom they can promote. The philosophy behind most of legal restric-
tions is connected with the presumed peculiar status of the state as the protector 
of the citizens and the institution ensuring their welfare. The most conspicuous 
assumption of such regulations is the weak position of helpless consumers, con-
trasted with the all-powerful status of mighty producers who would otherwise 
use all means imaginable to exploit and deceive the uneducated and vulnerable 
masses. It transpires from the very defi nition of disclaimers, which have been 
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described as a “statement of disclosure made with the purpose of clarifying or 
qualifying potentially misleading or deceptive statements made within an ad-
vertisement” (Stern and Harmon 1984: 13). It is quite clear that such a defi nition 
is based on the presumption that more and more companies deliberately fail to 
inform the customers about the potential risks or disadvantages, so the govern-
ment has no choice but to intervene.
There is a rich bulk of research, however, showing that such an assumption is 
actually wrong, and that deceitful practices are usually disadvantageous or even 
disastrous for dishonest and fraudulent entrepreneurs. These issues are discussed at 
length in Green and Armstrong (2012), who present them in the context of the ef-
fects of mandatory disclaimers in advertising. The authors convincingly argue that 
being honest and fair with the customers is in the advertisers’ best interest, and that 
there is no need to impose the placement of any obligatory disclosures in commer-
cials. Quite to the contrary: the evidence in form of a review of 18 experimental 
studies supplemented with their own experiment demonstrate that “the mandatory 
disclaimers caused confusion among consumers” and “[m]andated messages were 
ineffective or harmful in the 15 experiments that examined perceptions, attitudes 
or decisions” (Green and Armstrong 2012: 302). Yet, legally imposed disclaimers 
are still an integral part of contemporary advertising landscape.
On the other hand, it is quite clear that consumers have become used to 
the presence of disclosures in commercials and developed various strategies 
of dealing with them, ranging from total disregard to careful examination in 
search for any valuable information. The latter is obviously quite rare, most of 
the time we simply treat disclaimers as part of the background, an ingredient of 
the overall context, which has only a minor infl uence on the interpretation of the 
message (Wojtaszek 2007), especially in situations when the audience is famil-
iar with the advertised brand (Herbst, Hannah and Allan 2013). We have learnt 
that their content is predictable and largely irrelevant for our purchase decisions 
and general behaviour. In the context of advertisements for cigarettes and alco-
hol, whose consumption has been proven detrimental to our health beyond any 
doubt, the health risk warnings do not seem to be very effective in discouraging 
people from smoking or excessive drinking. The effects of any new regulations, 
imposing larger and larger fonts of such disclosures, occupying larger and larger 
part of the packaging, or even employing off-putting and distressing images of 
the effects of smoking or drinking, are only temporary.
The major focus of this paper, however, is not related to advertisements for 
potentially hazardous substances, and the disclaimers which are going to be 
analysed do not perform a predominantly warning function. That is why rather 
than being large and conspicuous, they occupy a much less prominent position 
in the commercials. Such disclaimers are most frequently found in advertise-
ments for pharmaceuticals (Hoek, Grendall, Rapson and Louviere 2011; van de 
Pol and de Bakker 2010) and dietary supplements (Dodge and Kaufman 2007; 
Mason, Scammon and Fang 2007), as well as in advertising targeted at children 
(Bakir 2009; Stutta and Hunnicutt 1987). Since the present paper focuses spe-
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cifi cally on commercials for erection stimulants, which fall within the scope of 
either pharmaceutical products or dietary supplements, the most relevant legal 
acts are the Regulation of the Minister of Health of 21 November 2008 on the 
advertising of medicinal products1 and the Regulation of the Minister of Health 
of 9 October 2007 on the composition and labelling of dietary supplements2. 
The former regulates the form of presenting references to scientifi c research, the 
required informational content of advertisements (including the composition 
of the product and the instructions for use), as well as the exact formulation in 
the Polish language of the well-known standard instruction to read the package 
leafl et before use3, while the latter focuses on listing the substances which may 
be used as the ingredients of dietary supplements and on the way in which the 
products must be labelled.
Precise instructions related to the form and manner of presentation of the 
disclosures, however, refer only to the advice to read the package leafl et of me-
dicinal products, specifying the size and orientation of the text, the line spacing 
and contrasting background requirements, the minimal duration of the display 
and the reading speed. The other elements imposed by the regulation must be 
displayed in a visible and readable manner, but the exact interpretation of what 
it actually means is left to the advertisers. The situation is similar in the case of 
disclaimers presented in the United States, regulated by the Federal Trade Com-
mission (FTC) (Quaresima 2011, April 20). Given the liberty of interpretation, 
the advertisers may relatively freely shape the presentation settings to suit their 
purposes. This most frequently results in very inconspicuous and rapid display 
of disclosures, which in turn signifi cantly infl uences their intake and interpreta-
tion by the viewers.
2.  The intake and interpretation of informative content 
in commercials
Many studies have been devoted to the issues related to the reception, 
understanding and appreciation of commercials, both in relation to the entire 
copies (Putrevu 2008; Zhang and Gelb 1996; Diao and Sundar 2004; Ketelaar, 
van Gisbergen, Bosman and Beentjes 2008) and a perspective limited to se-
lected elements (Harris, Sturm, Klassen and Bechtold 1986; van Mulken, van 
1 Rozporządzenie Ministra Zdrowia z dnia 21 listopada 2008 r. w sprawie reklamy produktów 
leczniczych, http://isap.sejm.gov.pl/DetailsServlet?id=WDU20082101327
2 Rozporządzenie Ministra Zdrowia z dnia 09 października 2007 r. w sprawie składu oraz ozna-
kowania suplementów diety, http://isap.sejm.gov.pl/DetailsServlet?id=WDU20071961425
3 „Przed użyciem zapoznaj się z treścią ulotki dołączonej do opakowania bądź skonsultuj się 
z lekarzem lub farmaceutą, gdyż każdy lek niewłaściwie stosowany zagraża Twojemu życiu lub 
zdrowiu” [Before use read the package leaflet or contact your doctor or pharmacist, because each 
drug used improperly threatens your life or health].
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Enschot-van Dijk and Hoeken 2005; Toncar and Munch 2001). The favourite 
aspects under investigation include the role of sexual appeal and sexual ref-
erences from the perspective of information processing (Alexander and Judd 
1978; Grazer and Keesling 1995; Reichert, Heckler and Jackson 2001; Sev-
ern, Belch and Belch 1990) or emotional responses, affect and arousal (Dud-
ley 1999; Huang M. H. 2004; LaTour and Henthorne 1993; LaTour, Pitts and 
Snook-Luther 1990; Reichert 2002), as well as studies of understanding and 
interpretation of metaphors in advertisements, represented by Ang (2002), Ang 
and Lim (2006), DeRosia (2008), Jeong (2008), Lagerwerf and Meijers (2008), 
Madupu and Cooley (2007), McQuarrie and Mick (1996; 1999; 2003), McQuar-
rie and Phillips (2005), Morgan and Reichert (1999), Pawlowski, Badzinski and 
Mitchell (1998), Phillips (1997; 2000), Phillips and McQuarrie (2004; 2009), 
Proctor, Proctor and Papasolomou (2005), Toncar and Munch (2001) van Mul-
ken, le Pair and Forceville (2010) and van Mulken, van Enschot-van Dijk and 
Hoeken (2005). 
In the context of the present investigation, however, the most relevant are 
the works concentrated on recall and evaluation of either the brand name or the 
advertising claims made in commercials, such as Bradley and Meeds (2002) 
Diao and Sundar (2004), Goodrich (2010), Grazer and Keesling (1995), Harris, 
Trusty, Bechtold and Wasinger (1989), Houston, Childers and Heckler (1987), 
Kaplan (2007), Lim, Ang, Lee and Leong (2009), Putrevu (2008), Reichert, 
Heckler and Jackson (2001), Toncar and Munch (2001) and Wojtaszek (2007; 
2009). The investigators collected their data by means of questionnaires, in-
terviews, text-completion tasks, recognition assignments or even recordings of 
observable behaviour. Their aim was not only revealing if a certain element had 
been remembered, but also how it had been integrated into the existing cogni-
tive framework and what had happened to the initial informational input.
It has been long established that our memory is a dynamic construct, de-
pending on re-creation of the original process or experience, rather than a static 
repository of events and sensations (Weiner and Craighead 2010: 589). On the 
neurological plane, in the act of remembering we attempt to repeat the original 
pattern of neural activation, while in the cognitive perspective we try to activate 
the same resources which contributed to the original experience. The problem 
is that in both domains we are doomed to failure, as it is impossible to recon-
struct the basic experience exactly in the same way, we cannot live through the 
same situation twice. What is more, it has been demonstrated that very often we 
are incapable of distinguishing between the elements of the new sensory input 
and the background knowledge already internalised in our mind. For example, 
McQuarrie and Phillips (2005) found that subjects tended to report positive 
claims about advertised products when such claims were made only indirectly, 
especially in form of a picture, which supports the fi ndings recounted in Kardes 
(1988) and Stayman and Kardes (1992). Harris, Trusty, Bechtold and Wasinger 
(1989), in turn, demonstrated that when we process advertising claims we have 
a tendency to treat and remember implied claims as actually stated, because the 
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linguistic markers of indirectness are usually neglected, a tendency confi rmed 
also by Wojtaszek (2007). The study found that the subjects not only applied 
modal modifi cations to the statements, but also tended to disregard specifi c 
components of the copies, especially the small print items, and use cohesive de-
vices to combine the abbreviated fragments into a larger whole. Finally and per-
haps most signifi cantly, however, Wojtaszek (2010a) and (2010b) demonstrated 
a consistent tendency to fabricate, whereby the subjects completing the task of 
elicited recall subconsciously supplemented the information derived from the 
advertisements used in the study with items typically found in similar messages, 
such as the GPS device in a car commercial.
This shows how strongly our perception depends on the existing knowledge 
base and how signifi cantly the informational input may be infl uenced by our pri-
or experiences. The contribution of the surrounding context and the background 
knowledge is schematically presented in a model of advertisement perception 
elaborated by Wojtaszek (2011: 204-206). The present study, however, is not con-
cerned with investigation of direct perception, but with focused content analy-
sis of TV commercials, on the basis of which hypothesised perception could be 
modelled. Rather than reporting on actual viewers’ impressions, it attempts to 
investigate in a detailed manner the exact content of the small print items and to 
evaluate their potential contribution to the mental processing of the commercials. 
Previous research has shown that disclaimers are customarily neglected and not 
attended to, primarily because they are incorporated into commercials in ways 
making their intake and processing extremely diffi cult or in combination with 
other, more salient elements, diverging the viewers’ attention from them (Wicks, 
Warren, Fosu and Wicks 2009). In connection with the above, it seemed intriguing 
to explore the ways in which the perception of TV commercials could be modifi ed 
if the content of all disclaimers was effectively absorbed. This is arguably a purely 
hypothetical situation, but on the other hand is it not a scientist’s obligation to 
pore over phenomena not normally discernible for a layperson?
3. The study design
The present investigation draws upon the collection of 20 TV commercials 
for erection stimulants which were broadcast in Poland between the years 2007 
and 20154. They were downloaded from the YouTube service and carefully in-
spected for the purpose of identifi cation of all informational content, with the 
4 The sample encompasses commercials for the following products: Braveran, Erekton, Erekton 
Fast, Liderin, Penigra, Permen, Permen Go, Permen King, Stymen and Vitasteron. The choice of 
this particular product group was directed by the author’s expectation that, given a taboo-related 
content of the commercials, the small-print disclosures will have to address issues which cannot be 
communicated explicitly. Additionally, restricting the scope of products guaranteed a more unified 
and homogeneous sample among all possible dietary supplements and pharmaceutical products.
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special focus on the disclaimers presented in small print. With the help of soft-
ware featuring a stop-frame functionality, all disclaimers were transcribed and 
the duration of their display was noted down. In this way the elements which 
normally escape attention or perceptive abilities of an average viewer could be 
subjected to analysis.
Saying that disclaimers are totally neglected in the process of viewing com-
mercials would be an overstatement. We do notice their presence, even expect 
them to be there, but seldom have enough time or determination to attend to 
their content (Doliński 2003). Leaving aside the issue of whether it is perceptu-
ally possible to read them, we can say that we choose not to, because we often 
assume that we actually know more or less what kind of message they contain. 
The present study will attempt to show if we are right in that assumption by 
revealing the complete content of the small print messages.
In addition to the above-mentioned objective, the investigation will also 
offer a preliminary typology of functions which the disclaimers perform in re-
lation to the more ostensibly presented elements of both textual and pictorial 
content, or perhaps even to the general contextual frame connected with the 
advertising situation. In this context, it will be investigated in what way the 
disclaimers complement the messages communicated in a conspicuous manner, 
whether they weaken the strength of the advertising claims and if they could be 
interpreted as a preventive measure against potential deceptive practices of the 
advertiser.
The analytical tool employed in the investigation is a selective content anal-
ysis, focused on the small print elements of the commercials. The functional 
classifi cation of the disclaimers (or their parts) will be the result of their bot-
tom-up qualitative analysis, vis-à-vis the remaining elements of the contextual 
embedding as schematically represented in the model of advertising message 
perception referred to earlier (Wojtaszek 2011).
4. The fi ndings
As mentioned earlier, the only obligatory disclosure whose precise formula-
tion, duration and form of presentation allowing for unproblematic comprehen-
sion is regulated by the Polish law is the instruction to read the package leafl et 
and consult the pharmacist or the doctor5. It is interesting that only 5 of the 
commercials under investigation contained this instruction. We might think that 
the remaining 15 should theoretically be banned from broadcasting, because 
5 Interestinlgy, there are a few commercials which incorporate this message in an inventive and 
untypical way, for example in recent TV ads for the sedative drugs Valerin Forte and Valerin 
Max the instruction is shouted by an agitated secondary character, apparently in need of some 
medication. In this way the manner of presentation of the disclosure serves at the same time as 
the illustration of the problem which the advertised drug helps to eliminate.
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they do not conform to the legal requirements. It turns out, however, that only 
1 of the 10 products is actually registered as a medicinal product (Stymen), the 
other ones only as dietary supplements. It means that the way in which they are 
advertised is not subject to the very strict constraints imposed by the Regulation 
of the Minister of Health on the advertising of medicinal products. There were 
3 commercials for this drug in the collection, which means that the instruction 
to read the package label was present in 2 other commercials, where it actually 
did not have to appear. The question is, then, why the advertisers decided to 
incorporate it into the spot.
One of the plausible answers is that in this way they wanted to make an 
impression that we are dealing with a medicinal product rather than with a mere 
dietary supplement. Since the customary instruction is displayed and read out in 
a conspicuous manner, the recipients are likely to classify the product as some-
thing more reliable and trustworthy. Many of them, however, will not probably 
know the difference between dietary supplements and medicinal products and 
the principles governing their advertising. Not everyone will not notice that the 
text is actually a bit shorter (the fragment because each drug used improperly 
threatens your life or health is missing) and displayed for 5 seconds instead 
of the required 8, either. Even so, the familiar text is nevertheless very likely 
to bring the desirable association with medicinal products and evoke positive 
associations with their reliability. In this context we can speak of deliberate 
manipulative function of this inclusion, because the commercial pretends to be 
something which it is not. Thus, in addition to the legally sanctioned warning 
and advisory function of the disclosure, we can sometimes come across its sec-
ondary, arguably manipulative, exploitation. Further investigation of the issue 
would require a more extensive inspection of a much larger sample of advertise-
ments containing the text and checking whether the products are registered as 
medicinal products or dietary supplements.
Another important function of the disclaimers can be described as dialogic 
or supplementary in relation to the text of the commercial presented conspicu-
ously either in spoken or written form. In the analysed advertisements we some-
times come across short statements presenting selected features of the prod-
uct, results of studies on product satisfaction or information about the problem 
which it is designed to help. Since the presentation of extended and complete 
information would consume the valuable advertising time, the advertisers very 
often opt for inclusion of such informational supplements in form of small print 
disclaimers.
In the commercial for Permen we are being informed that the product con-
tains double amount of L-arginine (Permen King) or even the highest dose of 
L-arginine (Permen Go). This is a typical component of commercial messag-
es – we come across comparative or superlative forms of adjectives or some 
sort of comparisons in the absence of the comparative element quite regularly 
(Bralczyk 2004; Wojtaszek 2002). Here, the point of reference is spelled out in 
the disclaimer. With perfect eyesight and exceptional reading speed we would 
216 ADAM WOJTASZEK
maybe manage to discern the text informing us that the exceptional quantity 
of L-arginine is gauged against the dose in the regular Permen medicine. In 
all probability, however, this is something different from what the majority of 
viewers would expect, namely, the comparison to products offered by com-
peting manufacturers. If this assumption is correct, minimizing the font and 
selecting a very short display time6 can be interpreted as a deliberate strategy to 
reduce drastically the chance for successful intake of the message and creating 
a false impression which is favourable for the advertiser.
In order to create a need for a new medical product advertisers very fre-
quently start with a suggestive description of a problem to which the advertised 
medicament offers a cure or relief. However, in the analysed sample the erectile 
dysfunction or problems related to low libido are referred to almost always in-
directly. Only in two spots for Permen products very specifi c data is reported, 
in form of the message that as many as 1.5 million men in Poland experience 
such ailment. This information is substantiated with a reference (in form of 
a small print disclosure) to the publication by Michał Rabijewski, „Zaburzenia 
erekcji – etiologia i leczenie” [Erectile dysfunction – etiology and treatment] 
published in 2006 in Przegląd Urologiczny [Urological Review]. Thus, we can 
talk here about another incarnation of the dialogic/supplementary function of 
disclaimers.
The third manifestation of the above-mentioned function can be found in 
small-print extensions of claims presenting the level of customer satisfaction 
or extraordinary performance of the product. Referring to the latter, we fi nd 
the claim in two of the Stymen commercials that the product almost triplicates 
male sexual performance, which is supported by a small print reference to the 
research by W.J. Reiter “Dehydroepiandrosterone in the treatment of erectile 
dysfunction” published in 1999 in Urology, while the positive results of pros-
terone supplementation mentioned in another Stymen ad are validated with 
a disclosure mentioning the 2007 publication by Michał Karasek „Hormony 
młodości?” in Endokrynologia Polska [Polish Endocrinology]. When it comes 
to the customers’ satisfaction reports, we fi nd them, for example, in Permen 
commercials: effectiveness of Permen has been acclaimed by thousands of men, 
making it the number 1 in Poland [skuteczność Permenu doceniło już tysiące 
mężczyzn, czyniąc go numerem 1 w Polsce], which the attentive viewers will 
notice linked to IMS Health Report on OTC drugs from 2009, or the claim that 
9 out of 10 men reported that they are satisfi ed with the performance of Permen 
King [badania pokazują, że 9 na 10 mężczyzn jest zadowolonych z działania 
Permen King], which in turn is supported with a small print reference to the 
quantitative report “Potency” by Millward Brown from September 2013. Leav-
ing aside the question to what degree the publications and reports mentioned in 
6 2 seconds for the single statement that the claim is made in comparison to the regular Permen 
product and 3 seconds for a similar statement displayed together with a detailed list of compo-
nents of the drug
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the disclosures were representative or reliable7, they do provide some evidence 
for the claims made in the commercials. They are all authentic sources which 
must have been reviewed and approved by appropriate authorities, so their vali-
dating value cannot be formally questioned.
Returning to the issue of explicit reference to problems related to sexual 
performance, apart from the information in the Permen ads about the defi ciency 
experienced by 1.5 million Polish men, no direct description is found. Only in 
the commercials for Stymen do we fi nd a mention of a specifi c medical condi-
tion, namely DHEA defi ciency, whose symptoms usually increase with age. The 
commercial includes a claim that the advertised product is capable of curing 
the condition and returning the user to full potency. The avoidance of direct 
reference to medical problems or dysfunctions in the remaining commercials is 
the result of the fact that almost all products advertised in the sample are reg-
istered as dietary supplements, not as medicinal products. Since Stymen is the 
exception, its advertisement can contain a description of a medical condition to-
gether with a suggestion that the medicament is capable of eliminating it. Closer 
scrutiny of the small print disclaimers in the three Stymen commercials allows 
for identifi cation of other required by law pieces of information: the specifi ca-
tion of the active pharmaceutical ingredient, the medical form of the drug, the 
list of contraindications, precise data on the company responsible for produc-
tion and distribution as well as the well-known instruction to read the package 
leafl et.
The knowledge that the other products belong to dietary supplements ena-
bles us to provide an explanation for the formulations which we fi nd in the 
disclaimers. They are very carefully phrased to avoid accusations of disallowed 
claims. Instead of telling us that the ingredients could help fi ght a specifi c prob-
lem or condition, they focus on the positive side, listing multiple benefi cial 
effects of the components. Let us look at an example from one of Braveran 
commercials:
tribulus terrestris boosts libido and sexual satisfaction; maca root helps to maintain 
natural sexual function and energy, boosts sexual drive, ginseng helps to stimulate 
and maintain erection, selenium assists in rejuvenation of spermatogenesis, zinc 
helps to maintain satisfactory testosterone level in blood
[buzdyganek ziemny wspomaga popęd seksualny oraz wzmacnia doznania seksu-
alne; maca pomaga w zachowaniu naturalnej aktywności seksualnej i energii, po-
budza popęd seksualny; żeń-szeń pomaga wywołać i wzmocnić erekcję; selen przy-
czynia się do prawidłowego przebiegu spermatogenezy; cynk pomaga w utrzymaniu 
prawidłowego poziomu testosteronu we krwi]
7 Some closer inspection of one of the sources (Reiter 1999) revealed that the results reported 
there were only preliminary, based on a very small sample and required support from subsequent 
studies.
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We can see that all these claims describe better functioning of an otherwise 
normal and healthy body, the impression that the ingredients could assist in 
curing any malfunction is exclusively the product of our inferences, for 
which the advertisers cannot be held legally responsible. We can fi nd simi-
lar formulations in the disclaimers attached to more than a half of the com-
mercials under investigation. The only advertisements which apply a slightly 
different strategy are the two commercials for Penigra, where we read the 
following:
Penigra is traditionally used by men with mild to average erectile dysfunction and 
with sexual desire disorders (low libido) as a sexual drive stimulant 
[Preparat Penigra jest stosowany tradycyjnie u mężczyzn z łagodnymi do umiarko-
wanych zaburzeniami erekcji oraz z zaburzeniami popędu płciowego (hypolibide-
mią) jako środek pobudzający popęd płciowy]
This looks a bit risky in the light of the law in force, but on the other hand 
saying that a certain substance is traditionally used by people suffering from 
a certain ailment is not, strictly speaking, equal to claiming that it actually cures 
the condition, especially that its effect is described as stimulating sexual drive. 
Thus, the advertisers would probably have no problems with arguing in court 
that they are not violating the law.
The producers of Permen are also treading on dangerous ground, because 
they use formulations very similar to those which were quoted earlier from 
the Braveran advertisement, but they do so after earlier explicit reference to 
the problems with erection suffered by 1.5 million Poles. Such a juxtaposition 
clearly aims at making a very strong impression that the product comes as a cure 
for that. However, the advertisers are very careful not to verbalise such a con-
nection in an explicit way. Again, we are not dealing with legal infringement, 
but with a clever and admittedly very successful attempt at manipulation. The 
same conclusion would be reached if we took into consideration only the explic-
itly formulated and conspicuously communicated claims.
If we come back to the commercial for Stymen, we can identify one more 
function of the small print disclaimer: weakening of the claim presented in ex-
plicit way. The voice over in the ad informs us that the drug permanently boosts 
sexual performance, while the disclosure presented in small print says that it 
restores proper DHEA level and that the androgenic activity is the result of 
testosterone production stimulation. The improvement of the sexual function is 
a very likely, but not a necessary consequence. Since such a weakening of one 
of the major claims is evidently disadvantageous for the advertiser, no wonder 
that the statement is formulated in highly specialised language and displayed for 
2 seconds only in a very small print.
Another pattern frequently found in the small print disclosures is an ex-
haustive list of all the components of the advertised product, together with ex-
actly specifi ed quantity of each of them. Such a message is communicated in 
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6 commercials separately and in addition to the description of the effects of 
the constituents, which was described above in connection with the dialogic/
supplementary function of the disclosures. Whenever such a list is provided, 
the uniqueness of the composition is emphasised. This kind of exceptional-
ity, however, is in fact nothing extraordinary: it would be in fact very diffi cult 
(and perhaps also illegal) to replicate the exact composition of another drug 
or dietary supplement, especially if the list of ingredients exceeds fi ve. Thus, 
it is very likely that in such cases we are dealing with a predominantly per-
suasive function of such a disclosure, applying the principle “the more – the 
better”, which has already been described in the literature (Wojtaszek 2002). 
This function could be described as overwhelming, because its major force 
lies in such an accumulation of positive features and benefi ts that the viewer 
is not capable of analyzing each of them separately and has a tendency to be-
lieve that since the advertiser decided to mention them all, the product must 
really be good. Such an interpretation is further supported by the subsequent 
listing in most of the ads of the positive effects of the ingredients on the sex-
ual function of the users, where the components of the dietary supplement are 
mentioned again.
The uniqueness of the composition is not highlighted only in three com-
mercials: in one of them the ingredients are only listed without any informa-
tion about their exact quantity or proportion, whereas two other ads (Penigra) 
contain only a short message describing the drug as complex product [produkt 
złożony], which is in fact all that the law requires in situations where dietary 
supplements have more than two active substances. In addition, it is worth men-
tioning one untypical commercial for Braveran, where the component substanc-
es, instead of being listed in the small print disclosures, are explicitly referred 
to both in written and spoken form and presented as one of the most important 
Unique Selling Points (UPS).
Finally, two minor functions of small print disclosures must be mentioned. 
The fi rst one is instructive in nature because it specifi es the usual dosage of the 
product and the method of taking – it was found only in 2 of the commercials 
under analysis. The second one could be named identifying, because it spelled 
out the name and the address of the producer of the advertised medicament – 
this information was present in 5 commercials for 2 products only – Permen and 
Stymen. Additionally, the producer of Liderin included the URL to the website 
where the information on the product could be accessed.
The producers of two advertised medicaments – Erekton and Vitasteron – 
did not include any small print disclosures at all. Since both the products are 
registered as dietary supplements, it wasn’t really necessary, but the viewers 
could potentially notice such an absence and it could infl uence the way in which 
the commercials were interpreted. The fact that in majority of the investigated 
advertisements more or less extensive disclosures were present indicates that 
the producers viewed their inclusion as benefi cial or important, both for them 
and for the viewers.
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5. Summary
The study has revealed that although the small print disclaimers pose a seri-
ous challenge for the perceptive abilities of the viewers, they nevertheless con-
stitute a very rich repository of information in most of the commercials under 
scrutiny. Although only in three of the analyzed commercials the inclusion of 
disclosures was imposed by the law (because the pharmaceutical was registered 
as a medicinal product), the majority of advertisements (15 out of 20) contained 
more or less extensive small print items. Scrupulous analysis of their content 
allowed for identifi cation of the following functions which they perform in con-
nection with their contextual embedding or the advertising situation in general:
• warning/advisory (the legally imposed instruction to read the Patient In-
formation Leafl et, sometimes exploited for persuasive/manipulative pur-
poses related to suggesting that the advertised product is a medically tested 
and licensed drug)
• dialogic/supplementary (providing details such as references to published 
research or surveys, points of reference for comparative statements or ex-
plicitly formulated claims, etc., whose inclusion in the body copy would 
take up to much advertising space or time or would be disadvantageous for 
the advertiser)
• weakening (limiting the value or strength of Unique Selling Points pre-
sented in the slogans and body copy, where the maximal suppression of 
such information is advantageous for the advertiser)
• overwhelming (accumulation of product features aiming at impressing the 
viewer and presenting the product as superior)
• instructive (information how to use the product)
• identifying (details about the producer)
It would be exceptional to fi nd all the above-mentioned functions represent-
ed in the disclaimers embedded within a single commercial, the average seems 
to oscillate between three to four.
Additionally, the study has revealed how important the exact formulation of 
even such perceptibly insignifi cant elements as small print disclaimers is. The 
advertisers must be very careful not to breach the legal regulations on the way 
to maximally effective persuasion, and the verbalizations appearing in the dis-
claimers are defi nitely products of very scrupulous legal analysis before they are 
incorporated in the commercial and broadcast. The examples presented above 
suggest that more often than not the advertisers resort to practices on the verge 
of outright manipulation or at least covert persuasion. Awareness of this fact 
would defi nitely facilitate such perception and understanding of commercial mes-
sages that would balance the advantages for the senders and receivers of adver-
tisements more fairly. The viewers would have a chance to notice that they are 
often exposed to unsubstantiated claims, biased information and manipulative 
disguise.
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Contrary to author’s expectation, no taboo topic explicating function of the 
disclaimers has been found. Even when the commercials which were analysed 
used some forms of indirectness or euphemisation in talking about sex-relat-
ed matters, the disclaimers did not participate in explicitation. The references 
to sexual activity were straightforward enough for everyone to interpret them 
without any major problem, which is probably the refl ection of the very open 
and uninhibited attitude towards sex characterising contemporary culture. In 
this situation, the functions of disclaimers identifi ed above could probably be 
extrapolated to commercials of all other dietary supplements and medical prod-
ucts. Further investigation of the issue focused on commercials of other phar-
maceuticals would allow to verify this tentative claim.
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